← All indications
Pneumonia, Viral
Inflammation of the lung parenchyma that is caused by a viral infection.
Subtype terms (1)
More specific conditions that are subtypes of Pneumonia, Viral in the MeSH hierarchy.
- COVID-19
1232 drugs (383 approved, 849 experimental)
Drugs by status
Phase 4 trials (7)
Phase 3 trials (18)
Phase 2 trials (36)
- mavrilimumab
- ciclesonide
- ibudilast
- nivolumab
- ozone
- pembrolizumab
- nitazoxanide
- nitric oxide
- vitamin c
- fondaparinux sodium
- colchicine
- mefloquine
- acetylsalicylic acid
- tocilizumab
- umbilical cord mesenchymal stem cells
- lactobacillus brevis
- lactobacillus plantarum
- lactobacillus helveticus
- chloroquine
- oxygen
- clopidogrel
- Streptococcus thermophilus
- pertechnetate
- melphalan
- tirofiban
- phosphate
- Lactobacillus acidophilus
- lactobacillus casei
- bifidobacterium lactis
- allogenic mesenchymal stem cell derived from olfactory mucosa
- +6 more
Phase 1 trials (3)
Organizations
Organization Involved with Phase 4 Indications (2)
Organization Involved with Phase 3 Indications (20)
- Ache Laboratorios Farmaceuticos S.A.
- Alexion
- Cristália Produtos Químicos Farmacêuticos Ltda.
- Rigel Pharmaceuticals
- Cairo University
- Centro di Riferimento Oncologico - Aviano
- Federal University of Juiz de Fora
- Hospital do Coracao
- Hospital Sirio-Libanes
- University of Versailles
- University of Copenhagen
- University of Modena and Reggio Emilia
- University of Trieste
- University of Montpellier
- EMS S/A
- Paris Diderot University
- University of Paris
- Istituto Nazionale Malattie Infettive Lazaro Spallanzani
- Albert Einstein Israelite Hospital
- Brazilian Research In Intensive Care Network
Organization Involved with Phase 2 Indications (66)
- MediciNova
- Immune Design
- Kamada, Ltd.
- Lung Biotechnology PBC
- Unipharm, Inc.
- Burnasyan Federal Medical Biophysical Center
- University of Roma La Sapienza
- Harvard University
- Danderyds Hospital
- Hospital Geral de Fortaleza
- MedSIR
- Rio de Janeiro State University
- Russian Academy of Medical Sciences
- University of Milan
- University of Parma
- Wuhan University
- Capital Medical University
- Xiamen University
- University of California, San Francisco
- Federal University of Rio de Janeiro
- Santa Casa de Misericórdia de Belo Horizonte
- Belarusian State Medical University
- Moscow State University
- Government of Russia
- ATCGen
- Ioannina University Hospital
- Karolinska Institute
- A.O. Ospedale Maggiore di Lodi
- University of Lyon
- The University of Hong Kong
- +36 more
Organization Involved with Phase 1 Indications (3)
Organization Involved with Other Experimental Indications (17)
- Clinica Virgen Milagrosa
- Grupo de Investigación Clínica en Oncología Radioterapia
- Hospital Universitario Madrid Sanchinarro
- Instituto Nacional de Cardiologia Ignacio Chavez
- Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
- Instituto Nacional de Enfermedades Respiratorias
- South Valley University
- Rovira i Virgili University
- Bellerophon Therapeutics
- Universidad Autonoma de Barcelona
- University of Brescia
- Ospedale di Bergamo
- Hospital Universitario Sant Joan de Reus
- Fundacion GenesisCare
- Hospital Vithas Valencia Consuelo
- Aferetica
- Unidad Temporal COVID-19 en Centro Citibanamex